{
    "clinical_study": {
        "@rank": "161459", 
        "acronym": "C-frost", 
        "arm_group": [
            {
                "arm_group_label": "Cryoballoon ablation", 
                "arm_group_type": "Experimental", 
                "description": "Cryoballoon ablation"
            }, 
            {
                "arm_group_label": "Cryoballoon after medical therapy", 
                "arm_group_type": "Active Comparator", 
                "description": "Cryoballoon ablation"
            }, 
            {
                "arm_group_label": "Cryoballoon as first-line therapy", 
                "arm_group_type": "Experimental", 
                "description": "Cryoballoon ablation"
            }, 
            {
                "arm_group_label": "Cryoballoon after failed drug therapy", 
                "arm_group_type": "Active Comparator", 
                "description": "Cryoballoon ablation"
            }
        ], 
        "brief_summary": {
            "textblock": "Cryoballoon ablation of paroxysmal atrial fibrillation can be used as first-line therapy\n      compared to second choice after failed medical therapy"
        }, 
        "brief_title": "Safety and Efficacy of Cryoballoon Ablation of Atrial Fibrillation as First-line Therapy", 
        "completion_date": {
            "#text": "April 2013", 
            "@type": "Actual"
        }, 
        "condition": "Paroxysmal Atrial Fibrillation", 
        "condition_browse": {
            "mesh_term": "Atrial Fibrillation"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  paroxysmal atrial fibrillation, symptomatic\n\n        Exclusion Criteria:\n\n          -  atrial fibrillation other than PAF, asymptomatic, previous AF ablation"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "May 1, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01920295", 
            "org_study_id": "3196568"
        }, 
        "intervention": {
            "arm_group_label": [
                "Cryoballoon ablation", 
                "Cryoballoon after medical therapy", 
                "Cryoballoon as first-line therapy", 
                "Cryoballoon after failed drug therapy"
            ], 
            "intervention_name": "Cryoballoon ablation", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "lastchanged_date": "August 7, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Ankara", 
                    "country": "Turkey", 
                    "zip": "06100"
                }, 
                "name": "Yuksek Ihtisas Heart-Education and Research Hospital"
            }
        }, 
        "location_countries": {
            "country": "Turkey"
        }, 
        "number_of_arms": "4", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Turkey: Ministry of Health", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "description": "At prespecified interval of 12th month from the index procedure occurence of Recurrent atrial fibrillation, atrial flutter and atrial tachycardia ( Number of Participants with Recurrent atrial fibrillation, atrial flutter and atrial tachycardia )was assessed using ambulatory holter ECG monitoring", 
                "measure": "Recurrent atrial fibrillation, atrial flutter and atrial tachycardia (composite)", 
                "safety_issue": "No", 
                "time_frame": "12 months from the procedure"
            }, 
            {
                "description": "At prespecified interval of 3rd month from the index procedure occurence of Recurrent atrial fibrillation, atrial flutter and atrial tachycardia ( Number of Participants with Recurrent atrial fibrillation, atrial flutter and atrial tachycardia )was assessed using ambulatory holter ECG monitoring", 
                "measure": "Recurrent atrial fibrillation, atrial flutter and atrial tachycardia (composite)", 
                "safety_issue": "No", 
                "time_frame": "3 months from the procedure"
            }, 
            {
                "description": "At prespecified interval of 6th month from the index procedure occurence of Recurrent atrial fibrillation, atrial flutter and atrial tachycardia ( Number of Participants with Recurrent atrial fibrillation, atrial flutter and atrial tachycardia )was assessed using ambulatory holter ECG monitoring", 
                "measure": "Recurrent atrial fibrillation, atrial flutter and atrial tachycardia (composite)", 
                "safety_issue": "No", 
                "time_frame": "6 months from the procedure"
            }, 
            {
                "description": "At prespecified interval of 9th month from the index procedure occurence of Recurrent atrial fibrillation, atrial flutter and atrial tachycardia ( Number of Participants with Recurrent atrial fibrillation, atrial flutter and atrial tachycardia )was assessed using ambulatory holter ECG monitoring", 
                "measure": "Recurrent atrial fibrillation, atrial flutter and atrial tachycardia (composite)", 
                "safety_issue": "No", 
                "time_frame": "9 months from the procedure"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01920295"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Yuksek Ihtisas Hospital", 
            "investigator_full_name": "Serkan Cay", 
            "investigator_title": "Associate Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Yuksek Ihtisas Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Yuksek Ihtisas Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2011", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "August 2013"
    }
}